Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001213900-25-044863·Cue Biopharma, Inc.
Schedule 13G ownership disclosure
CUE BIOPHARMA INC
Common Stock, $0.001 par value per share · CUSIP: 22978P106
Event date: 2022-11-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Mark E. Strome
Shares: 2,166,242.00 · Class: 4.99%
- Strome Mezzanine Fund, LP
Shares: 46,103.00 · Class: 0.11%
- Strome Mezzanine Fund II, LP
Shares: 1,907,281.00 · Class: 4.39%
- Strome Dynasty, LLC.
Shares: 162,629.00 · Class: 0.38%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-044863
- Form type
- SCHEDULE 13G/A
- Filer
- Cue Biopharma, Inc.
- CIK
- CIK 1645460
- Filed
- May 16, 2025
- Reporting period
- Nov 14, 2022
- Description
- Schedule 13G beneficial ownership